Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | TG Therapeutics, Inc. TGTX |
The Vanguard Group | 15,596,480 10.010% |
1,925,536 (+14.08%) |
Filing History |
| 2024-11-14 7:45 pm Sale |
2024-09-30 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 0 0.000% |
-4,046,598 (Position Closed) |
Filing History |
| 2024-10-07 4:08 pm Purchase |
2024-09-30 | 13G | TG Therapeutics, Inc. TGTX |
BLACKROCK INC BLK |
21,956,312 14.200% |
11,188,149 (+103.90%) |
Filing History |
| 2024-02-14 3:30 pm Sale |
2023-12-31 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 4,046,598 2.700% |
-6,404,643 (-61.28%) |
Filing History |
| 2024-02-13 5:15 pm Sale |
2023-12-29 | 13G | TG Therapeutics, Inc. TGTX |
The Vanguard Group | 13,670,944 9.030% |
-1,831,820 (-11.82%) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | TG Therapeutics, Inc. TGTX |
BLACKROCK INC BLK |
10,768,163 7.100% |
1,635,273 (+17.91%) |
Filing History |
| 2024-01-25 11:29 am Sale |
2023-12-31 | 13G | TG Therapeutics, Inc. TGTX |
STATE STREET CORP STT |
8,253,573 5.450% |
-2,161,588 (-20.75%) |
Filing History |
| 2023-04-03 08:00 am Purchase |
2023-03-22 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 10,451,241 7.100% |
10,451,241 (New Position) |
Filing History |
| 2023-02-09 12:39 pm Sale |
2023-02-09 | 13G | TG Therapeutics, Inc. TGTX |
FMR CORP | 7,188,862 4.946% |
-865,599 (-10.75%) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | TG Therapeutics, Inc. TGTX |
The Vanguard Group | 15,502,764 10.670% |
756,372 (+5.13%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | TG Therapeutics, Inc. TGTX |
STATE STREET CORP STT |
10,415,161 7.170% |
7,009,856 (+205.85%) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | TG Therapeutics, Inc. TGTX |
BLACKROCK INC BLK |
9,132,890 6.300% |
230,725 (+2.59%) |
Filing History |
| 2022-10-11 10:07 am Purchase |
2022-09-30 | 13G | TG Therapeutics, Inc. TGTX |
The Vanguard Group | 14,746,392 10.150% |
2,654,955 (+21.96%) |
Filing History |
| 2022-07-11 08:49 am Sale |
2022-07-08 | 13G | TG Therapeutics, Inc. TGTX |
FMR CORP | 8,054,461 5.576% |
-12,666,970 (-61.13%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | TG Therapeutics, Inc. TGTX |
The Vanguard Group | 12,091,437 8.460% |
1,120,574 (+10.21%) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | TG Therapeutics, Inc. TGTX |
FMR CORP | 20,721,431 14.496% |
5,894,295 (+39.75%) |
Filing History |
| 2022-02-01 5:08 pm Purchase |
2021-12-31 | 13G | TG Therapeutics, Inc. TGTX |
BLACKROCK INC BLK |
8,902,165 6.200% |
345,879 (+4.04%) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | TG Therapeutics, Inc. TGTX |
GREAT POINT PARTNERS LLC | 0 0.000% |
-5,434,783 (Position Closed) |
Filing History |
| 2021-02-10 4:49 pm Sale |
2021-01-31 | 13G | TG Therapeutics, Inc. TGTX |
RA Capital Management, L.P. | 6,361,123 4.700% |
-2,324,348 (-26.76%) |
Filing History |
| 2021-02-10 4:34 pm Sale |
2020-12-31 | 13G | TG Therapeutics, Inc. TGTX |
RA Capital Management, L.P. | 8,685,471 6.400% |
-4,102,986 (-32.08%) |
Filing History |